Key facts
- This page summarizes Robert L. Davidow's Form 4 filing for AVENUE THERAPEUTICS, INC. (ATXI).
- 6 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 13 Dec 2023, 16:02.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Sale
Sale
Sale
Sale
Sale
Additional SEC filing notes
Footnote F1
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.13 to $0.15, inclusive. Each sale price was below the purchase prices for the shares, and the reporting person engaged in the transactions for tax purposes and to cause his holdings to fall below 10% of the outstanding shares of the issuer's common stock and thereby cease being subject to the requirements of Section 16 of the Securities Exchange Act of 1934. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
Footnote F2
Consists of shares of common stock held in a joint account with the Reporting Person's wife.
Footnote F3
Consists of shares of common stock held in trusts for the benefit of the Reporting Person's children in which the Reporting Person is the trustee.
Footnote F4
Consists of shares of common stock held in accounts maintained for the benefit of certain individuals or trusts over which the Reporting Person has shared voting and dispositive authority.
Footnote F5
Consists of shares of commons stock held in accounts maintained for the benefit of certain individuals or trusts over which the Reporting Person has shared dispositive authority.
Footnote F6
Consists of shares of common stock held by the Reporting Person's wife.